Company news: CVS, LiveStrong

CVS is getting serious about generics, and has knocked off a few brand names from its PBM formulary for 2013, reported the Wall Street Journal. The Journal noted that the drugstore chain started eliminating high-cost prescriptions over the summer. Some of these have made their way back onto the formulary, including Lilly/BI's Tradjenta, but the drug store chain is striking Allergan's glaucoma medicine Lumigan, Pfizer's human growth hormone Genotropin and the BMS/AstraZeneca diabetes med Onglyza, reported the WSJ.

Shifting gears faster than some expected, the Livestrong Foundation and Lance Armstrong have parted ways, reported the New York Times. The disgraced cyclist and cancer survivor founded the Livestrong foundation in 1997. Although he resigned as chair, following the United States Anti-Doping Agency's conclusion that Armstrong was guilty of doping while competing for the Tour de France, he was still a member of the board until November 4, reported the Times. He was stripped of his Tour titles and banned from future Olympics sports. Jeff Garvey has replaced him as chairman.
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.